Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T82463
|
|||||
Target Name |
Cocaine (Coca)
|
|||||
Gene Name |
NOUNIPROTAC
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Cocaine use disorder [ICD-11: 6C45] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | TNX-1300 | Drug Info | Phase 2 | Cocaine addiction | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Degrader | [+] 1 Degrader drugs | + | ||||
1 | TNX-1300 | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Tonix Pharmaceuticals. | |||||
REF 2 | ClinicalTrials.gov (NCT01846481) A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse (RBP-8000). U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.